Danone North America supporting users of weight loss medications with Oikos Fusion
Danone North America has announced it will launch Oikos Fusion, a high-nutrient dense dairy drink specifically made to assist users of GLP-1 weight-loss drugs to retain muscle mass and digestive health.
It is said that in the United States, some 27% of the population is currently on some on some weight loss regime and some 10% are using GLP-1 medication.
Oikos Fusion is designed to help build and retain muscle mass during weight loss when combined with exercise and a balanced diet. It offers a combination of whey protein, leucine and vitamin D, three key nutrients in muscle mass support.
"Pairing Danone's decades of science expertise with the Oikos' brand's emphasis on strength and high-quality protein enabled us to create something truly unique for people looking to maintain muscle mass while on a weight loss journey," said Rafael Acevedo, president of yogurt at Danone North America. "The growing need for tailored nutrition solutions for people experiencing muscle mass loss is something we can expertly tackle. We know change takes strength and we believe weight loss isn't only about taking things away — it's about adding and strengthening routines with nutrient-dense products that help people better meet their goals."
Oikos Fusion comes in three flavors including Strawberry, Mixed Berry, and Vanilla. Each nutrient-dense 7 fl. oz, 130-calorie bottle is lactose-free and contains:
"People on a weight loss journey often eat less, so it's crucial to focus on the nutrient density of the foods they do eat. When protein needs are not met, the body will start breaking down muscle to get the amino acids it needs. Fiber is also important considering its role in digestive health and because most American fall short on fiber intake," explains Whitney Evans PhD, RD, director of nutrition and scientific affairs at Danone North America.
